Intestinal ultrasound measurement of bowel wall thickness can be used as a sole marker for defining anti-TNF maintenance therapy failure in Crohn’s disease
Our findings suggest that BWT alone may be used as a single ultrasonographic marker of treatment, therefore simplifying the use of IUS. Using a single objective ultrasonographic parameter simplifies the use of IUS, an important factor that can facilitate the use of this important imaging technique.
Authors
- Lior Dar (ORCID: https://orcid.org/0000-0003-1560-5910)
- Shomron Ben‐Horin (ORCID: https://orcid.org/0000-0002-3984-4580)
- Ahmad Albshesh (ORCID: https://orcid.org/0000-0001-8962-4263)
- Shehadeh Haj
- Uri Kopylov (ORCID: https://orcid.org/0000-0002-7156-0588)
- Ido Veisman (ORCID: https://orcid.org/0000-0003-0490-0607)
- Ohad Regev (ORCID: https://orcid.org/0000-0001-8964-5582)
- Dan Carter (ORCID: https://orcid.org/0000-0001-7979-6803)
Institutions
- Ben-Gurion University of the Negev (IL)
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1177/17562848251343008
- Citations
- 3
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 5.45